Abnormal methylation of septin 9 (SEPT9) is one of the most frequently reported events [9, 10], and the SEPT9 methylation test has already been approved by the Food and Drug Administration in early screening for colorectal carcinoma [11]. Here, SEPTIN9 is linked to colorectal carcinoma.